Lobe Sciences (XCNQ:LOBE) Scaled Net Operating Assets : 0.51 (As of May. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Lobe Sciences Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Lobe Sciences's operating assets for the quarter that ended in May. 2024 was C$1.93 Mil. Lobe Sciences's operating liabilities for the quarter that ended in May. 2024 was C$0.86 Mil. Lobe Sciences's Total Assets for the quarter that ended in Feb. 2024 was C$2.11 Mil. Therefore, Lobe Sciences's scaled net operating assets (SNOA) for the quarter that ended in May. 2024 was 0.51.

Lobe Sciences Scaled Net Operating Assets Historical Data

The historical data trend for Lobe Sciences's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences Scaled Net Operating Assets Chart

Lobe Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Aug19

Aug20

Aug21

Aug22

Aug23

Scaled Net Operating Assets

Get a 7-Day Free Trial

811.43

1.82

0.30

-0.04

0.02

Lobe Sciences Quarterly Data
	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24
Scaled Net Operating Assets	Get a 7-Day Free Trial															-	-	-0.16	-0.40	0.51

Competitive Comparison of Lobe Sciences's Scaled Net Operating Assets

For the Biotechnology subindustry, Lobe Sciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lobe Sciences's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lobe Sciences's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Lobe Sciences's Scaled Net Operating Assets falls into.

Lobe Sciences Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Lobe Sciences's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Aug. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Aug. 2023 )
=	(Operating Assets (A: Aug. 2023 )	-	Operating Liabilities (A: Aug. 2023 ))	/	Total Assets (A: Aug. 2022 )
=	(2.159	-	2.127)	/	1.748
=	0.02

where

	Operating Assets		(A: Aug. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	2.299	-	0.14
=	2.159

	Operating Liabilities		(A: Aug. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	2.46	-	0	-	0.333
=	2.127

Lobe Sciences's Scaled Net Operating Assets (SNOA) for the quarter that ended in May. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: May. 2024 )
=	(Operating Assets (Q: May. 2024 )	-	Operating Liabilities (Q: May. 2024 ))	/	Total Assets (Q: Feb. 2024 )
=	(1.931	-	0.859)	/	2.109
=	0.51

where

	Operating Assets		(Q: May. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	1.961	-	0.03
=	1.931

	Operating Liabilities		(Q: May. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	3.073	-	1.934	-	0.28
=	0.859

Lobe Sciences Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Lobe Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (XCNQ:LOBE) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

LOBEF:USA 6YX0:Germany

Address

1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5

Website

https://www.lobesciences.com

Lobe Sciences Ltd is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.

Lobe Sciences Headlines

No Headlines